nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Triamcinolone—psoriatic arthritis	0.844	1	CbGbCtD
Mivacurium—Hypoxemia—Methotrexate—psoriatic arthritis	0.0131	0.0842	CcSEcCtD
Mivacurium—Hypoxia—Methotrexate—psoriatic arthritis	0.00414	0.0266	CcSEcCtD
Mivacurium—Wheezing—Triamcinolone—psoriatic arthritis	0.00387	0.0248	CcSEcCtD
Mivacurium—Urticaria—Auranofin—psoriatic arthritis	0.00385	0.0247	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.00325	0.0209	CcSEcCtD
Mivacurium—Rash—Auranofin—psoriatic arthritis	0.00306	0.0196	CcSEcCtD
Mivacurium—Dermatitis—Auranofin—psoriatic arthritis	0.00305	0.0196	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00299	0.0192	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00298	0.0191	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00271	0.0174	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00271	0.0174	CcSEcCtD
Mivacurium—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00245	0.0158	CcSEcCtD
Mivacurium—Bradycardia—Prednisolone—psoriatic arthritis	0.00222	0.0142	CcSEcCtD
Mivacurium—Bradycardia—Triamcinolone—psoriatic arthritis	0.00204	0.0131	CcSEcCtD
Mivacurium—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00203	0.0131	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00197	0.0127	CcSEcCtD
Mivacurium—Arrhythmia—Prednisolone—psoriatic arthritis	0.00194	0.0125	CcSEcCtD
Mivacurium—Erythema—Prednisolone—psoriatic arthritis	0.00189	0.0122	CcSEcCtD
Mivacurium—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00185	0.0119	CcSEcCtD
Mivacurium—Bradycardia—Betamethasone—psoriatic arthritis	0.00185	0.0119	CcSEcCtD
Mivacurium—Bradycardia—Dexamethasone—psoriatic arthritis	0.00185	0.0119	CcSEcCtD
Mivacurium—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00181	0.0116	CcSEcCtD
Mivacurium—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.0018	0.0116	CcSEcCtD
Mivacurium—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0018	0.0116	CcSEcCtD
Mivacurium—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00179	0.0115	CcSEcCtD
Mivacurium—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00178	0.0115	CcSEcCtD
Mivacurium—Erythema—Triamcinolone—psoriatic arthritis	0.00174	0.0112	CcSEcCtD
Mivacurium—Erythema—Methylprednisolone—psoriatic arthritis	0.00174	0.0112	CcSEcCtD
Mivacurium—Angiopathy—Dexamethasone—psoriatic arthritis	0.00165	0.0106	CcSEcCtD
Mivacurium—Angiopathy—Betamethasone—psoriatic arthritis	0.00165	0.0106	CcSEcCtD
Mivacurium—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00162	0.0104	CcSEcCtD
Mivacurium—Arrhythmia—Betamethasone—psoriatic arthritis	0.00162	0.0104	CcSEcCtD
Mivacurium—Bradycardia—Prednisone—psoriatic arthritis	0.00161	0.0103	CcSEcCtD
Mivacurium—Erythema—Dexamethasone—psoriatic arthritis	0.00158	0.0101	CcSEcCtD
Mivacurium—Erythema—Betamethasone—psoriatic arthritis	0.00158	0.0101	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00155	0.00993	CcSEcCtD
Mivacurium—Tachycardia—Prednisolone—psoriatic arthritis	0.00151	0.00969	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00147	0.00944	CcSEcCtD
Mivacurium—Flushing—Prednisone—psoriatic arthritis	0.00147	0.00942	CcSEcCtD
Mivacurium—Angiopathy—Prednisone—psoriatic arthritis	0.00143	0.00921	CcSEcCtD
Mivacurium—Immune system disorder—Prednisone—psoriatic arthritis	0.00143	0.00917	CcSEcCtD
Mivacurium—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00142	0.00913	CcSEcCtD
Mivacurium—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00142	0.00911	CcSEcCtD
Mivacurium—Arrhythmia—Prednisone—psoriatic arthritis	0.00141	0.00907	CcSEcCtD
Mivacurium—Tachycardia—Triamcinolone—psoriatic arthritis	0.00139	0.00891	CcSEcCtD
Mivacurium—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00138	0.00889	CcSEcCtD
Mivacurium—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00138	0.00885	CcSEcCtD
Mivacurium—Erythema—Prednisone—psoriatic arthritis	0.00138	0.00884	CcSEcCtD
Mivacurium—Hypotension—Methylprednisolone—psoriatic arthritis	0.00133	0.00851	CcSEcCtD
Mivacurium—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00129	0.00828	CcSEcCtD
Mivacurium—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00129	0.00828	CcSEcCtD
Mivacurium—Tachycardia—Betamethasone—psoriatic arthritis	0.00126	0.00808	CcSEcCtD
Mivacurium—Tachycardia—Dexamethasone—psoriatic arthritis	0.00126	0.00808	CcSEcCtD
Mivacurium—Urticaria—Prednisolone—psoriatic arthritis	0.00123	0.00789	CcSEcCtD
Mivacurium—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00123	0.00788	CcSEcCtD
Mivacurium—Hypotension—Betamethasone—psoriatic arthritis	0.00121	0.00774	CcSEcCtD
Mivacurium—Hypotension—Dexamethasone—psoriatic arthritis	0.00121	0.00774	CcSEcCtD
Mivacurium—Angiopathy—Methotrexate—psoriatic arthritis	0.0012	0.0077	CcSEcCtD
Mivacurium—Immune system disorder—Methotrexate—psoriatic arthritis	0.00119	0.00766	CcSEcCtD
Mivacurium—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00119	0.00765	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00116	0.00747	CcSEcCtD
Mivacurium—Erythema—Methotrexate—psoriatic arthritis	0.00115	0.00739	CcSEcCtD
Mivacurium—Urticaria—Triamcinolone—psoriatic arthritis	0.00113	0.00725	CcSEcCtD
Mivacurium—Urticaria—Methylprednisolone—psoriatic arthritis	0.00113	0.00724	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00112	0.00721	CcSEcCtD
Mivacurium—Tachycardia—Prednisone—psoriatic arthritis	0.0011	0.00704	CcSEcCtD
Mivacurium—Skin disorder—Prednisone—psoriatic arthritis	0.00109	0.00701	CcSEcCtD
Mivacurium—Urticaria—Betamethasone—psoriatic arthritis	0.00102	0.00658	CcSEcCtD
Mivacurium—Urticaria—Dexamethasone—psoriatic arthritis	0.00102	0.00658	CcSEcCtD
Mivacurium—Dizziness—Prednisolone—psoriatic arthritis	0.00102	0.00656	CcSEcCtD
Mivacurium—Rash—Prednisolone—psoriatic arthritis	0.000975	0.00626	CcSEcCtD
Mivacurium—Dermatitis—Prednisolone—psoriatic arthritis	0.000974	0.00625	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000973	0.00625	CcSEcCtD
Mivacurium—Dizziness—Triamcinolone—psoriatic arthritis	0.00094	0.00604	CcSEcCtD
Mivacurium—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000939	0.00603	CcSEcCtD
Mivacurium—Dizziness—Methylprednisolone—psoriatic arthritis	0.000938	0.00602	CcSEcCtD
Mivacurium—Skin disorder—Methotrexate—psoriatic arthritis	0.000912	0.00586	CcSEcCtD
Mivacurium—Rash—Triamcinolone—psoriatic arthritis	0.000897	0.00576	CcSEcCtD
Mivacurium—Dermatitis—Triamcinolone—psoriatic arthritis	0.000896	0.00575	CcSEcCtD
Mivacurium—Rash—Methylprednisolone—psoriatic arthritis	0.000895	0.00574	CcSEcCtD
Mivacurium—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000894	0.00574	CcSEcCtD
Mivacurium—Urticaria—Prednisone—psoriatic arthritis	0.000893	0.00573	CcSEcCtD
Mivacurium—Hypotension—Methotrexate—psoriatic arthritis	0.000877	0.00563	CcSEcCtD
Mivacurium—Dizziness—Betamethasone—psoriatic arthritis	0.000853	0.00548	CcSEcCtD
Mivacurium—Dizziness—Dexamethasone—psoriatic arthritis	0.000853	0.00548	CcSEcCtD
Mivacurium—Rash—Dexamethasone—psoriatic arthritis	0.000814	0.00522	CcSEcCtD
Mivacurium—Rash—Betamethasone—psoriatic arthritis	0.000814	0.00522	CcSEcCtD
Mivacurium—Dermatitis—Betamethasone—psoriatic arthritis	0.000813	0.00522	CcSEcCtD
Mivacurium—Dermatitis—Dexamethasone—psoriatic arthritis	0.000813	0.00522	CcSEcCtD
Mivacurium—Urticaria—Methotrexate—psoriatic arthritis	0.000746	0.00479	CcSEcCtD
Mivacurium—Dizziness—Prednisone—psoriatic arthritis	0.000743	0.00477	CcSEcCtD
Mivacurium—Rash—Prednisone—psoriatic arthritis	0.000708	0.00455	CcSEcCtD
Mivacurium—Dermatitis—Prednisone—psoriatic arthritis	0.000708	0.00454	CcSEcCtD
Mivacurium—Dizziness—Methotrexate—psoriatic arthritis	0.000621	0.00399	CcSEcCtD
Mivacurium—Rash—Methotrexate—psoriatic arthritis	0.000592	0.0038	CcSEcCtD
Mivacurium—Dermatitis—Methotrexate—psoriatic arthritis	0.000592	0.0038	CcSEcCtD
